News

A trial of ClearFlow’s PleuraFlow Active Clearance Technology (ACT) has demonstrated the value in adding the system into ...
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - ...
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
The global cardiac surgery devices market is estimated to be worth USD 1.8 billion in 2024 and is projected to grow at a CAGR ...
Select patients with heart failure fitted with an implantable left ventricular assist device can be safely moved to a stepdown unit (SDU) from intensive care unit (ICU), reducing costs ...
Wearable heart sound devices mark a groundbreaking shift in cardiac care, enabling continuous, non-invasive monitoring and transforming the prevention, diagnosis, and treatment of cardiovascular ...